| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/17/2004 | US20040116494 N-[(S)-2-diphenylamino-1-(5-oxo4,5-dihydro[1,3,4]oxadiazol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide or N-((S)-1-carbamoyl-2-diphenylamino-ethyl)-2-(2-methylaminopyrimidin-4-yl)-1H-benzimidazole-5-carboxamide; chronic pain |
| 06/17/2004 | US20040116490 Compounds and methods |
| 06/17/2004 | US20040116489 (1S*,2S*,4S*,5R*,6S*) 2-Amino-4-(3-phenylthioureido)-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid for treatment of neurological disorders and psychiatric disorders |
| 06/17/2004 | US20040116487 Novel oxazole derivatives |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116485 Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 06/17/2004 | US20040116483 Glucagon antagonists/inverse agonists |
| 06/17/2004 | US20040116482 Potassium channel opener |
| 06/17/2004 | US20040116481 Remedial agent for chronic articular rheumatism |
| 06/17/2004 | US20040116479 Method of inhibiting angiogenesis |
| 06/17/2004 | US20040116478 Novel amlodipine camsylate and method for preparing thereof |
| 06/17/2004 | US20040116474 Novel pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 06/17/2004 | US20040116473 useful in the treatment of TGF- beta related disease states including, for example, cancer and fibrotic diseases |
| 06/17/2004 | US20040116472 inhibit angiogenesis, tumor metastasis and growth, osteoporosis, Paget's disease, hypercalcemia of malignancy, retinopathy, macular degeneration, arthritis, periodontal disease, smooth muscle cell migration and viral diseases |
| 06/17/2004 | US20040116471 Indolylpiperidine derivatives as antihistaminic aand antiallergic agents |
| 06/17/2004 | US20040116470 by virtue of intracellular metabolic stimulation; delivery kit as a local anesthetic for dental surgical use |
| 06/17/2004 | US20040116468 Therapeutic agent for glomerular disease |
| 06/17/2004 | US20040116467 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents |
| 06/17/2004 | US20040116466 Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
| 06/17/2004 | US20040116465 Novel compounds |
| 06/17/2004 | US20040116463 excellent in stability than amorphous one and are more preferable for treatment of hyperlipidemia and atherosclerosis |
| 06/17/2004 | US20040116462 Antiinflammatory agents |
| 06/17/2004 | US20040116461 Immunomodulatory compounds |
| 06/17/2004 | US20040116460 Anticancer agents |
| 06/17/2004 | US20040116459 Remedies for vesical hyperactivity |
| 06/17/2004 | US20040116458 Chemical compounds |
| 06/17/2004 | US20040116457 Agents for improving excretory potency of urinary bladder |
| 06/17/2004 | US20040116456 Remedies for psychoneurosis |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116452 Aminipiperidine compound; bactericides |
| 06/17/2004 | US20040116451 Method of treatment |
| 06/17/2004 | US20040116450 Antipruritics |
| 06/17/2004 | US20040116449 Using a pyrrolo(2,3-d)pyrimidine compound |
| 06/17/2004 | US20040116448 Substances for the therapy of diseases caused by highly proliferating cells |
| 06/17/2004 | US20040116447 Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists |
| 06/17/2004 | US20040116446 Nitrogen compounds having improved solubility, bioavailability and stability, used as sedatives, anxiolytics, anticonvulsant, and/ or muscle relaxants for prophylaxis of sleep disorders |
| 06/17/2004 | US20040116445 Substituted thioacetamides |
| 06/17/2004 | US20040116443 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 06/17/2004 | US20040116441 Antagonist as immunomodulators for cardiovascular disorders, antiinflammatory agents and treatment of other conditions |
| 06/17/2004 | US20040116440 Useful for diagnosis, treatment of male or female sexual dysfunction |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116438 Compositions for treatment of cell proliferation disorders |
| 06/17/2004 | US20040116437 5HT2C Receptor agonist for treatment of disorders of central nervous system such as obsessive compulsive disorders, depression or anxiety |
| 06/17/2004 | US20040116436 Treatment with Brimonidine for nervous system disorders |
| 06/17/2004 | US20040116435 Benzimidazol derivatives modulate chemokine receptors |
| 06/17/2004 | US20040116434 Ocular therapy |
| 06/17/2004 | US20040116433 Triazolo[4,3b]pyridazine to inhibit activity of serine/threonine protein kinases tor treatment of cancer with administering |
| 06/17/2004 | US20040116432 Triazolo[4,3b]pyridazine as kinase inhibitors for treatment of cancerin mammals |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/17/2004 | US20040116427 Compounds for inhibition of HIV infection by blocking HIV entry |
| 06/17/2004 | US20040116426 Small molecules useful in the treatment of inflammatory disease |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/17/2004 | US20040116420 Remedial agent for viral infectious disease |
| 06/17/2004 | US20040116419 Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals |
| 06/17/2004 | US20040116418 Compounds and methods for inhibition of HIV and related viruses |
| 06/17/2004 | US20040116417 Thiohydantoins and use thereof for treating diabetes |
| 06/17/2004 | US20040116416 having immunomodulating and cytokine-release-inhibiting action |
| 06/17/2004 | US20040116415 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers |
| 06/17/2004 | US20040116413 useful against a number of human and veterinary pathogens, including gram-positive aerobic bacteria such as multiply-resistant staphylococci and streptococci, anaerobic organisms such as bacteroides and clostridia species, and acid-fast organisms |
| 06/17/2004 | US20040116411 and at least one antiretroviral drug, such as nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors and integrase inhibitors |
| 06/17/2004 | US20040116410 Diazepinones as antiviral agents |
| 06/17/2004 | US20040116409 staurosporine derivative to treat Epiretinal membrane (ERM) formation |
| 06/17/2004 | US20040116408 therapeutic di- or tri-hydroxy derivatives of eicosapentaenoic acid or docosahexaenoic acid that diminish, prevent, or eliminate inflammation |
| 06/17/2004 | US20040116407 therapy involving the use of pentamidine, or an analog of pentamidine, and chlorpromazine, or an analog of chlorpromazine |
| 06/17/2004 | US20040116406 for the treatment of disorders of the central nervous system such as cerebral, central nervous or psychiatric symptoms, defunctionalization manifestations or disorders which occur as a result of unintentional or intentional intake of psychotropic |
| 06/17/2004 | US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
| 06/17/2004 | US20040116404 Sulphones which modulate the action of gamma secretase |
| 06/17/2004 | US20040116403 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 06/17/2004 | US20040116402 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 06/17/2004 | US20040116401 Diagnosis and treatment of human kidney diseases |
| 06/17/2004 | US20040116400 Compounds, compositions, and methods |
| 06/17/2004 | US20040116398 Therapeutic applications of estrogenic carboxylic acids |
| 06/17/2004 | US20040116397 2-methoxyestradiol and its analogues, with and without synergistic compounds (namely eugenol) |
| 06/17/2004 | US20040116395 Combinations for the treatment of inflammatory disorders |
| 06/17/2004 | US20040116394 broad-spectrum anticancer effect, primarily mediated by the inhibition of Protein Kinase C activity and induction of the apoptotosis of cancer cells |
| 06/17/2004 | US20040116393 Prevention of epithelial cancer |
| 06/17/2004 | US20040116392 obtaining such microparticles using a fluid-bed granulation technique; small size of the microparticles ensures a fast and predictable emptying from the stomach and controllable plasma levels of the absorbed drug |
| 06/17/2004 | US20040116391 prodrug will be hydrolyzed in the stomach or the gut into thyroxine and the biologically inert dimethylphosphinic acid |
| 06/17/2004 | US20040116390 Use of creatine analogues and creatine kinase modulators for the prevention and treatment of obesity and its related disorders |
| 06/17/2004 | US20040116388 triazine compoound inhibitors of enzymes that catalyze phosphoryl transfer and/or that bind ATP/GTP nucleotides |
| 06/17/2004 | US20040116387 thyroid receptor ligands, preferably antagonists for the treatment of cardiac and metabolic disorders, such as cardiac arrhythmias, thyrotoxicosis, subcllinical hyperthyrodism and liver diseases |
| 06/17/2004 | US20040116385 bound to carboranyl groups; kills or inhibits the human immunodeficiency virus |
| 06/17/2004 | US20040116383 has no toxicity, and have a unique curative effect, without influence on the trip and living, so that it can be used widely for a long period |
| 06/17/2004 | US20040116381 Method of predicting the structural integrity of mamalian tissue |
| 06/17/2004 | US20040116380 enhance a host's immune defense mechanisms to infection but do not induce an inflammatory response |
| 06/17/2004 | US20040116379 capable of enhancing efficacy of vaccines; capable of enhancing the action of an agent in preventing tissue rejection |
| 06/17/2004 | US20040116378 Novel composition and method for the treatment of diabetes |
| 06/17/2004 | US20040116377 Rhamnan sulphate composition for treatment of endothelial dysfunction |
| 06/17/2004 | US20040116375 Method of treating bone metastasis |
| 06/17/2004 | US20040116374 C2, 8-disubstituted adenosine derivatives and their different uses |
| 06/17/2004 | US20040116373 purine base or a salt thereof for preparing a promoter for saccharide uptake in epidermal keratinocytes |
| 06/17/2004 | US20040116370 a nucleic acid encoding an immunogenic polypeptide; a lipid; and a transition metal enhancer ZnCl2 |
| 06/17/2004 | US20040116369 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 06/17/2004 | US20040116362 Novel nucleosides and related processes, pharmaceutical compositions and methods |
| 06/17/2004 | US20040116361 Antihelminthic anthraquinones and method of use thereof |
| 06/17/2004 | US20040116360 Dissolving a polyene antibiotic and a poly(ethylene glycol)-phospholipid in a solvent to produce a solution; evaporating the solvent; adding water to the drug-polymer film and mixing vigorously, whereby micelles are formed |
| 06/17/2004 | US20040116359 Administering 16 alpha -bromo-3 beta -hydroxy-5 alpha -androstan-17-one hemihydrate and one or more excipients for therapy of pathogen infection, an autoimmune disease, inflammation or allergy, osteoporosis, acute myelitis, sarcoidosis, a cancer |
| 06/17/2004 | US20040116358 Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors |
| 06/17/2004 | US20040116356 To stimulate proliferation of fibroblasts or keratinocytes and/or stimulate production of collagen by fibroblasts; useful for treating gum- and skin-related conditions |